Acute liver injury and IgG4-related autoimmune pancreatitis following mRNA-based COVID-19 vaccination [0.03%]
基于mRNA的COVID-19疫苗接种后的急性肝损伤和IgG4相关性自身免疫性胰腺炎
Ankoor H Patel,Rajan Amin,Alexander T Lalos
Ankoor H Patel
IgG4-related disease (IgG4-RD) is a fibro-inflammatory disease that can affect multiple organs. Autoimmune pancreatitis type 1 is a manifestation of IgG4-RD and can often mimic tumor-like masses. Autoimmune phenomena following COVID-19 mRNA...
Case Reports
Hepatology forum. 2022 Sep 23;3(3):97-99. DOI:10.14744/hf.2022.2022.0019 2022
Cell-free methylation of RASSF1 and CDKN2AIP genes in the diagnosis of hepatocellular carcinoma associated with hepatitis B virus cirrhosis [0.03%]
乙型肝炎病毒肝硬化的肝细胞癌诊断中rassf1和cdkn2aip基因无细胞甲基化检测价值分析
Pelin Telli,Nazli Begum Ozturk,Mehmet Tolgahan Hakan et al.
Pelin Telli et al.
Background and aim: Chronic hepatitis B virus (HBV) infection is a major cause of hepatocellular carcinoma (HCC). Circulating cell-free DNA (cfDNA) methylation of tumor suppressor genes are emerging potential biomarkers i...
Nazli Begum Ozturk,Haris Muhammad,Merve Gurakar et al.
Nazli Begum Ozturk et al.
With the increasing incidence and prevalence of end-stage liver disease, demand for donor grafts continues to increase. Approaches on maximizing the potential donor grafts vary depending on the region. This review aims to summarize the curr...
Toxic hepatitis case with prolonged jaundice due to Favipiravir [0.03%]
因 favipiravir 导致的长期黄疸型中毒性肝炎病例报告
Ramazan Yolacan,Umit Karabulut,Ali Uzel et al.
Ramazan Yolacan et al.
Favipiravir (FPV) is an antiviral drug used in the treatment of severe acute respiratory syndrome coronavirus 2 infection. The main side effects of this drug are teratogenicity and hyperuricemia. Limited information is available on other si...
Case Reports
Hepatology forum. 2022 Sep 23;3(3):95-96. DOI:10.14744/hf.2022.2022.0007 2022
Palliative care in cirrhotic patients: Brief summary of recent AASLD guidance [0.03%]
肝硬化患者姑息治疗的简述及近期AASLD指南分析
Osman Cavit Ozdogan
Osman Cavit Ozdogan
Palliative care in decompensated cirrhotic patients is a developing concept which should be used in cirrhotic patients during the advanced and terminal stages. Hepatologists and liver transplant teams mostly ignore the patients palliative c...
Preliminary Report of the ministry of health working group on standardization of living donor liver transplantation in Turkiye [0.03%]
土耳其卫生部活体肝移植标准化工作组初步报告
Veysel Umman,Murat Zeytunlu,Zeki Karasu et al.
Veysel Umman et al.
Liver transplantation is successfully achieved all over the world and in Turkiye. Similar to many middle and far east countries, donation from deceased donors has not reached the desired level in Turkiye. Therefore, in Turkiye, living donor...
Development of hepatocellular carcinoma in patients with chronic hepatitis C who had sustained viral response following direct-acting antiviral therapy [0.03%]
直接抗病毒治疗后持续病毒学反应的慢性丙型肝炎患者发生肝细胞癌的发病风险
Berat Ebik,Mustafa Aygan,Elif Tugba Tuncel et al.
Berat Ebik et al.
Background and aim: Several studies have suggested that treatment with direct-acting antivirals (DAAs) in patients with chronic hepatitis C virus (HCV) may be associated with an increased risk of developing hepatocellular...
NSAID-associated drug-induced liver injury prior to and following liver transplantation [0.03%]
肝移植前后非甾体抗炎药物引起的药源性肝损伤
Mesut Gumussoy,Hale Gokcan,Emin Bodakci et al.
Mesut Gumussoy et al.
Characteristics of patients with hepatocellular carcinoma: A multicenter study [0.03%]
中国四家医院肝细胞癌患者的临床特征多中心研究
Fatih Guzelbulut,Umit Karaogullarindan,Hikmet Akkiz et al.
Fatih Guzelbulut et al.
Background and aim: The aim of the present study was to examine the etiology of hepatocellular carcinoma (HCC) by underlying cause and determine the characteristics and clinical features of patients with HCC. ...
Cagatay Ak,Gupse Adali,Suleyman Sayar et al.
Cagatay Ak et al.
Background and aim: Portal vein thrombosis (PVT) is particularly detected in advanced liver cirrhosis patients. We aimed to analyze the risk factors for PVT in liver transplant candidates. ...